Press Release Distribution
Pricing
Customer Support
(800) 998-2927
Login
Log In
All Categories
Business
Entertainment
Health
Finance
Other
Tagged
tikomed
Press Release
Mar 13, 2020
TIKOMED Secures 5M Euro Funding for the Clinical Development of ILB™ and IBSOLVMIR®
Read More
Press Release
Mar 9, 2020
Locust Walk Appointed Strategic and Business Development Advisor for the Licensing Process of ILB™
Read More
Press Release
Mar 4, 2019
TFS International AB (TFS) Appointed CRO Representative for TIKOMED's Phase 2 Study in Clinical Islet Transplantation
Read More
Press Release
Feb 8, 2019
TIKOMED Successfully Closed Fundraising of 8 Million Euros
Read More
Press Release
Feb 6, 2019
Shadow Lake Group Appointed Strategic Advisor and Business Development Representative for the Licensing Process of IBsolvMIR® in Canada
Read More
Press Release
Nov 19, 2018
TIKOMED Granted Permission for Phase 2 Clinical Trial in Islet Cell Transplantation by the Swedish Medical Product Agency
Read More
Press Release
Nov 2, 2018
First Patient Treated With ILB in TIKOMED's Clinical Trial for ALS
Read More
Press Release
Aug 20, 2018
Tikomed to Initiate ALS Clinical Trial for Which the UK Medicines and Healthcare Products Regulatory Agency Has Granted Permission
Read More
Press Release
Aug 14, 2018
TIKOMED Announce Start of ALS Study at Sahlgrenska University Hospital
Read More
Press Release
May 29, 2018
ILB - a Game Changer in Glaucoma
Read More
Press Release
May 28, 2018
Tikomed Granted Permission for Clinical Trial in ALS by the Swedish Medical Product Agency and Ethical Review Board.
Read More
First
Prev
1
Next
Last
